Nuzenio

Loss Pipeline

Loss Pipeline news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 5 publisher sources 100/100 entity strength

Latest news

GYRE: Q2 2026 revenue reached $29.1M, net loss widened, and Cullgen acquisition expanded the pipeline - TradingViewTradingView · Fri, 07 Aug 2026 12:06:56 GMT JANX: Clinical pipeline advanced and net loss narrowed, supported by nearly $1B in liquidity - TradingViewTradingView · Thu, 06 Aug 2026 20:28:46 GMT ALEC: Advanced ABC platform pipeline and reduced net loss, with cash runway through 2027 - TradingViewTradingView · Thu, 06 Aug 2026 20:26:22 GMT RLAY: Net loss widened on higher R&D, but strong cash reserves support pipeline progress into 2029 - TradingViewTradingView · Thu, 06 Aug 2026 20:17:52 GMT AEye Reports Q2 2026 Revenue $0.2M, GAAP Loss $10.0M; Commercial Pipeline at Record Level - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMT CRVS: Strong cash position and advancing clinical pipeline drive growth despite higher net loss - TradingViewTradingView · Thu, 06 Aug 2026 20:03:28 GMT WHWK: Q2 2026 net loss narrowed to $16.6M, cash runway extended to 2H 2028, and pipeline advanced - TradingViewTradingView · Thu, 06 Aug 2026 14:11:49 GMT IFRX: Advanced pipeline in AAV and renal diseases, with strong funding and reduced net loss - TradingViewTradingView · Thu, 06 Aug 2026 13:19:12 GMT

Timeline

Fri, 07 Aug 2026 12:06:56 GMTGYRE: Q2 2026 revenue reached $29.1M, net loss widened, and Cullgen acquisition expanded the pipeline - TradingView

Thu, 06 Aug 2026 20:28:46 GMTJANX: Clinical pipeline advanced and net loss narrowed, supported by nearly $1B in liquidity - TradingView

Thu, 06 Aug 2026 20:26:22 GMTALEC: Advanced ABC platform pipeline and reduced net loss, with cash runway through 2027 - TradingView

Thu, 06 Aug 2026 20:17:52 GMTRLAY: Net loss widened on higher R&D, but strong cash reserves support pipeline progress into 2029 - TradingView

Thu, 06 Aug 2026 20:13:04 GMTAEye Reports Q2 2026 Revenue $0.2M, GAAP Loss $10.0M; Commercial Pipeline at Record Level - TradingView

Thu, 06 Aug 2026 20:03:28 GMTCRVS: Strong cash position and advancing clinical pipeline drive growth despite higher net loss - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

TradingView TradingView18 live mentions Revenue4 live mentions Advanced4 live mentions Million4 live mentions Indian Pharma Post3 live mentions Cullgen2 live mentions Clinical2 live mentions Advanced ABC2 live mentions Net2 live mentions GAAP Loss2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Loss Pipeline.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.